Eagle Pharmaceuticals to Present at November Conferences

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) announced today that Scott Tarriff, President and Chief Executive Officer, and David Riggs, Chief Financial Officer, will each present at two conferences in November as follows:

Each presentation will be webcast live at the aforementioned times, and archived for 90 days thereafter, via the company’s website at www.eagleus.com, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151112005377/en/

In-Site Communications, Inc.
Lisa M. Wilson, 212-452-2793
President

Source: Eagle Pharmaceuticals, Inc.

You May Also Be Interested In

• The Leon Levine Foundation Awards $3.25M to Expand Career-Connected Learning Across the Carolinas
• NX Development Corp. Celebrates One-Year Anniversary of Gleolan(R) Commercial Control With Record-Breaking Sales
• ZETA SURGICAL® Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics